NOVEL 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE BEARING AS SUBSTITUENT GROUP PHENYL GROUP HAVING SULFONIC ESTER OR SULFONAMIDE STRUCTURE INTRODUCED THEREINTO AND EXHIBITING GLUCOCORTICOID RECEPTOR BINDING ACTIVITY
PROBLEM TO BE SOLVED: To provide a novel 1,2,3,4-tetrahydroquinoxaline derivative or a salt thereof that bears, as a substituent group, a phenyl group having a sulfonic ester or sulfonamide structure introduced thereinto, and a medicinal composition. SOLUTION: The compound represented by general for...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | TAKAI YOSHIKAZU NAGATSUKA SANETOSHI MATSUDA MANABU KOBAYASHI SACHIKO KATO MASATOMO MORI TOSHIYUKI |
description | PROBLEM TO BE SOLVED: To provide a novel 1,2,3,4-tetrahydroquinoxaline derivative or a salt thereof that bears, as a substituent group, a phenyl group having a sulfonic ester or sulfonamide structure introduced thereinto, and a medicinal composition. SOLUTION: The compound represented by general formula (1) or a salt thereof is useful as a glucocorticoid receptor modulator. In the formula, R1, R2, R3, R4, R5, R6and R7are each a hydrogen atom, a lower alkyl group or the like; W and X are each an oxygen atom, a sulfur atom or the like; Y is a lower alkylene group or the like; Z is an oxygen atom, a sulfur atom, NR9, OCO or OSO2; and R9is a hydrogen atom, a lower alkyl group or the like. COPYRIGHT: (C)2009,JPO&INPIT |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2009007344A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2009007344A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2009007344A3</originalsourceid><addsrcrecordid>eNqNjkFKxEAQRbNxIeodCtcZiJOAuOx016RL2q5YXR0mq2GQdiU6MB7VA5mRHMDV538-j3dd_USeMMBDva3butsoqhg_O-HXTJH3JlBEcCg0GaUJoUcjFAcwCVLuk5JmjAqDcB5h9BjnsBZvpssx5bDjSBYwKQqwrIt5IYeQVLLVLAgUVdhliw7Uo-DSGUx0gHtPPemFNYRs2bIoWSYHghZHXYg9RfcnZRdH0vm2uno_fpzL3Zo31f0O1fpNOX0dyvl0fCuf5fvwPG6b5qlpHtuuM-2_Tr8u5VSh</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE BEARING AS SUBSTITUENT GROUP PHENYL GROUP HAVING SULFONIC ESTER OR SULFONAMIDE STRUCTURE INTRODUCED THEREINTO AND EXHIBITING GLUCOCORTICOID RECEPTOR BINDING ACTIVITY</title><source>esp@cenet</source><creator>TAKAI YOSHIKAZU ; NAGATSUKA SANETOSHI ; MATSUDA MANABU ; KOBAYASHI SACHIKO ; KATO MASATOMO ; MORI TOSHIYUKI</creator><creatorcontrib>TAKAI YOSHIKAZU ; NAGATSUKA SANETOSHI ; MATSUDA MANABU ; KOBAYASHI SACHIKO ; KATO MASATOMO ; MORI TOSHIYUKI</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a novel 1,2,3,4-tetrahydroquinoxaline derivative or a salt thereof that bears, as a substituent group, a phenyl group having a sulfonic ester or sulfonamide structure introduced thereinto, and a medicinal composition. SOLUTION: The compound represented by general formula (1) or a salt thereof is useful as a glucocorticoid receptor modulator. In the formula, R1, R2, R3, R4, R5, R6and R7are each a hydrogen atom, a lower alkyl group or the like; W and X are each an oxygen atom, a sulfur atom or the like; Y is a lower alkylene group or the like; Z is an oxygen atom, a sulfur atom, NR9, OCO or OSO2; and R9is a hydrogen atom, a lower alkyl group or the like. COPYRIGHT: (C)2009,JPO&INPIT</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090115&DB=EPODOC&CC=JP&NR=2009007344A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090115&DB=EPODOC&CC=JP&NR=2009007344A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TAKAI YOSHIKAZU</creatorcontrib><creatorcontrib>NAGATSUKA SANETOSHI</creatorcontrib><creatorcontrib>MATSUDA MANABU</creatorcontrib><creatorcontrib>KOBAYASHI SACHIKO</creatorcontrib><creatorcontrib>KATO MASATOMO</creatorcontrib><creatorcontrib>MORI TOSHIYUKI</creatorcontrib><title>NOVEL 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE BEARING AS SUBSTITUENT GROUP PHENYL GROUP HAVING SULFONIC ESTER OR SULFONAMIDE STRUCTURE INTRODUCED THEREINTO AND EXHIBITING GLUCOCORTICOID RECEPTOR BINDING ACTIVITY</title><description>PROBLEM TO BE SOLVED: To provide a novel 1,2,3,4-tetrahydroquinoxaline derivative or a salt thereof that bears, as a substituent group, a phenyl group having a sulfonic ester or sulfonamide structure introduced thereinto, and a medicinal composition. SOLUTION: The compound represented by general formula (1) or a salt thereof is useful as a glucocorticoid receptor modulator. In the formula, R1, R2, R3, R4, R5, R6and R7are each a hydrogen atom, a lower alkyl group or the like; W and X are each an oxygen atom, a sulfur atom or the like; Y is a lower alkylene group or the like; Z is an oxygen atom, a sulfur atom, NR9, OCO or OSO2; and R9is a hydrogen atom, a lower alkyl group or the like. COPYRIGHT: (C)2009,JPO&INPIT</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjkFKxEAQRbNxIeodCtcZiJOAuOx016RL2q5YXR0mq2GQdiU6MB7VA5mRHMDV538-j3dd_USeMMBDva3butsoqhg_O-HXTJH3JlBEcCg0GaUJoUcjFAcwCVLuk5JmjAqDcB5h9BjnsBZvpssx5bDjSBYwKQqwrIt5IYeQVLLVLAgUVdhliw7Uo-DSGUx0gHtPPemFNYRs2bIoWSYHghZHXYg9RfcnZRdH0vm2uno_fpzL3Zo31f0O1fpNOX0dyvl0fCuf5fvwPG6b5qlpHtuuM-2_Tr8u5VSh</recordid><startdate>20090115</startdate><enddate>20090115</enddate><creator>TAKAI YOSHIKAZU</creator><creator>NAGATSUKA SANETOSHI</creator><creator>MATSUDA MANABU</creator><creator>KOBAYASHI SACHIKO</creator><creator>KATO MASATOMO</creator><creator>MORI TOSHIYUKI</creator><scope>EVB</scope></search><sort><creationdate>20090115</creationdate><title>NOVEL 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE BEARING AS SUBSTITUENT GROUP PHENYL GROUP HAVING SULFONIC ESTER OR SULFONAMIDE STRUCTURE INTRODUCED THEREINTO AND EXHIBITING GLUCOCORTICOID RECEPTOR BINDING ACTIVITY</title><author>TAKAI YOSHIKAZU ; NAGATSUKA SANETOSHI ; MATSUDA MANABU ; KOBAYASHI SACHIKO ; KATO MASATOMO ; MORI TOSHIYUKI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2009007344A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>TAKAI YOSHIKAZU</creatorcontrib><creatorcontrib>NAGATSUKA SANETOSHI</creatorcontrib><creatorcontrib>MATSUDA MANABU</creatorcontrib><creatorcontrib>KOBAYASHI SACHIKO</creatorcontrib><creatorcontrib>KATO MASATOMO</creatorcontrib><creatorcontrib>MORI TOSHIYUKI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TAKAI YOSHIKAZU</au><au>NAGATSUKA SANETOSHI</au><au>MATSUDA MANABU</au><au>KOBAYASHI SACHIKO</au><au>KATO MASATOMO</au><au>MORI TOSHIYUKI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE BEARING AS SUBSTITUENT GROUP PHENYL GROUP HAVING SULFONIC ESTER OR SULFONAMIDE STRUCTURE INTRODUCED THEREINTO AND EXHIBITING GLUCOCORTICOID RECEPTOR BINDING ACTIVITY</title><date>2009-01-15</date><risdate>2009</risdate><abstract>PROBLEM TO BE SOLVED: To provide a novel 1,2,3,4-tetrahydroquinoxaline derivative or a salt thereof that bears, as a substituent group, a phenyl group having a sulfonic ester or sulfonamide structure introduced thereinto, and a medicinal composition. SOLUTION: The compound represented by general formula (1) or a salt thereof is useful as a glucocorticoid receptor modulator. In the formula, R1, R2, R3, R4, R5, R6and R7are each a hydrogen atom, a lower alkyl group or the like; W and X are each an oxygen atom, a sulfur atom or the like; Y is a lower alkylene group or the like; Z is an oxygen atom, a sulfur atom, NR9, OCO or OSO2; and R9is a hydrogen atom, a lower alkyl group or the like. COPYRIGHT: (C)2009,JPO&INPIT</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_JP2009007344A |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | NOVEL 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE BEARING AS SUBSTITUENT GROUP PHENYL GROUP HAVING SULFONIC ESTER OR SULFONAMIDE STRUCTURE INTRODUCED THEREINTO AND EXHIBITING GLUCOCORTICOID RECEPTOR BINDING ACTIVITY |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T17%3A41%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TAKAI%20YOSHIKAZU&rft.date=2009-01-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2009007344A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |